118,947 Shares in Astera Labs, Inc. (NASDAQ:ALAB) Acquired by Natixis

Natixis purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 118,947 shares of the company's stock, valued at approximately $15,755,000. Natixis owned 0.07% of Astera Labs as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Dimensional Fund Advisors LP raised its holdings in Astera Labs by 4.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 18,250 shares of the company's stock worth $2,417,000 after acquiring an additional 768 shares during the period. First Trust Advisors LP increased its position in Astera Labs by 78.3% during the fourth quarter. First Trust Advisors LP now owns 123,901 shares of the company's stock worth $16,411,000 after acquiring an additional 54,413 shares during the period. GeoWealth Management LLC acquired a new position in Astera Labs during the 4th quarter valued at $114,000. Canada Pension Plan Investment Board acquired a new stake in Astera Labs in the 4th quarter worth $26,596,000. Finally, NewEdge Advisors LLC acquired a new position in shares of Astera Labs during the fourth quarter valued at about $63,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Stock Up 7.3 %

NASDAQ:ALAB traded up $4.40 during mid-day trading on Thursday, reaching $64.55. 3,014,025 shares of the company were exchanged, compared to its average volume of 3,814,369. Astera Labs, Inc. has a 12 month low of $36.22 and a 12 month high of $147.39. The stock has a market cap of $10.47 billion and a PE ratio of -37.31. The company has a fifty day moving average of $67.36 and a 200 day moving average of $90.97.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. On average, equities research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have commented on ALAB. Barclays raised their price objective on Astera Labs from $87.00 to $135.00 and gave the stock an "overweight" rating in a research report on Friday, January 17th. Stifel Nicolaus lowered their price target on shares of Astera Labs from $150.00 to $100.00 and set a "buy" rating on the stock in a report on Thursday, April 17th. Raymond James initiated coverage on shares of Astera Labs in a report on Friday, March 14th. They set an "outperform" rating and a $82.00 price objective for the company. Northland Capmk raised shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, January 28th. Finally, Northland Securities raised Astera Labs from a "market perform" rating to an "outperform" rating and set a $120.00 price objective on the stock in a report on Tuesday, January 28th. One research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Buy" and an average target price of $109.25.

Insider Transactions at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 350,680 shares of the company's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $89.51, for a total transaction of $31,389,366.80. Following the completion of the sale, the chief executive officer now owns 2,353,655 shares in the company, valued at approximately $210,675,659.05. The trade was a 12.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, General Counsel Philip Mazzara sold 7,536 shares of the firm's stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $92.07, for a total value of $693,839.52. Following the completion of the transaction, the general counsel now owns 241,209 shares in the company, valued at $22,208,112.63. This represents a 3.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 633,990 shares of company stock worth $54,235,012 in the last quarter.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.